September 15, 2023 from CannaBizEU
SOMAÍ Pharmaceuticals is a large-scale manufacturer of cannabis products, focusing on the highest quality medical-grade uses. They separate and purify primary bulk APIs of cannabinoids such THC, THCa, CBD, and CBN. They use the most recent technology and comply with the strictest pharmaceutical standards.
On 1st of September SOMAÍ shared breaking news about their recent developments: EU-GMP Certification for its facility in Portugal and €5 million capital raise. Thus, we decided to talk about this achievement with Michael Sassano, SOMAÍ’s CEO and Founder.
